MedPath

Efficacy of Volume Ventilation in Patients With Acute Respiratory Failure at Risk of Obstructive Apneas or Obesity Hypoventilation

Not Applicable
Conditions
Hypercapnic Respiratory Failure
Acute Respiratory Failure
Respiratory Acidosis
Apnea, Obstructive
Obesity
Hypoventilation Syndrome
Interventions
Device: AVAPS-AE mode during NIV
Device: S/T mode during NIV
Registration Number
NCT04131660
Lead Sponsor
University Hospital, Rouen
Brief Summary

This study compares a volume targeted pressure support non-invasive ventilation with an automatic PEP regulation (AVAPS-AE mode) to a pressure support non-invasive ventilation (S/T mode) in patients with acute hypercapnic respiratory failure with acidosis. This study focuses on patients at risk of obstructive apneas or obesity-hypoventilation syndrom (BMI≥30 kg/m²). Half of participants (33 patients) will receive non invasive ventilation with AVAPS-AE mode, the other half will receive non-invasive ventilation with S/T mode.

Detailed Description

So far, in respiratory intensive care units, the usual treatment of patients with acute hypercapnic respiratory failure with acidosis is non-invasive ventilation set with a pressure support mode (S/T or VS/AI mode depending on the ventilator manufacturer).

AVAPS-AE mode is a volume targeted pressure support mode with an automatic PEP. With the forced oscillations method, the ventilator is able to detect the obstruction and the resistances of upper airways.

It allows the ventilator to change its pressure settings to keep the targeted volume and avoid apneas and hypoventilation.

That is why in patients with a BMI \> 30 kg/m², at risk of obesity hypoventilation syndrom or obstructive apneas, this ventilation mode may be interesting.

AVAPS-AE has been evaluated in the home ventilation showing it is as efficient as S/T mode in controlling PaCO2.

However it has never been compared to S/T mode in acute respiratory failure care.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
66
Inclusion Criteria
  • Patient of age
  • Patient benefitting of social security
  • Informed patient who signed the information note and the research enlighted consent form
  • Admission in respiratory intensive care unit for an acid-hypercapnic exacerbation (defined by pH≤ 7,35)
  • BMI ≥ 30kg/m2
  • PaCO2 > 6.5 kPa on blood gases at ICU admission
Exclusion Criteria
  • Confirmed COPD with a spirometry (VEMS/CVF < 70%)
  • Pregnant women, or breast-feeding women
  • Patient with a judiciary or administrative liberty deprivation
  • Patients under guardianship
  • Contraindication to NIV

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AVAPS-AE modeAVAPS-AE mode during NIVA volume targeted pressure support ventilation mode
S/T modeS/T mode during NIVA pressure support ventilation mode
Primary Outcome Measures
NameTimeMethod
Resolution of hypercapniathrough study completion, an average of 1 year

Time between admission and resolution of hypercapnia (≤ 6.5 kPa)

Secondary Outcome Measures
NameTimeMethod
Comparison of persistent apneic events on NIV (/h) during the first nightthrough study completion, an average of 1 year

Comparison of persistent apneic events on NIV (/h) during the first night (determined with a respiratory polygraph) between S/T mode arm and AVAPS-AE mode arm (determined with an oxymeter)

Comparison of time during NIV with a oxygen saturation below 90%through study completion, an average of 1 year

Comparison of time during NIV with a oxygen saturation below 90% between S/T mode arm and AVAPS-AE mode arm (determined with an oxymeter)

Comparison of NIV confortthrough study completion, an average of 1 year

Comparison of NIV confort between S/T mode arm and AVAPS-AE mode arm (NIV confort determined by a visual scale: 0: very comfortable to 10:not comfortable at all)

Comparison of patient-ventilator asynchronisms during NIV (/h)through study completion, an average of 1 year

Comparison of patient-ventilator asynchronisms during NIV (/h) between S/T mode arm and AVAPS-AE mode arm (determined with ventilator datas and a respiratory polygraph)

Comparison of length of staythrough study completion, an average of 1 year

Comparison of length of stay between S/T mode arm and AVAPS-AE mode arm

© Copyright 2025. All Rights Reserved by MedPath